Despite their effectiveness, concerns remain regarding safety, tolerability and potential health risks, as well as the need for long-term administration and the subsequent cost
A clinical trial using lixisenatide in early Parkinsons patients demonstrated slowed progression of motor symptoms: the treated group had stable MDS-UPDRS Part III scores ( = 0.04), while the placebo group showed worsening disability ( = +3.04) ( Evidence also suggests antidepressant effects of GLP-1RAs
How do I recover faster, get back to full strength sooner, and not just sit around waiting for time to pass
[DOI] [PubMed] [Google Scholar] 109.Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS
GP participation is voluntary, so coverage varies significantly by integrated care board (ICB, the regional NHS body that decides whats funded locally)
Timing: Inject on the same day each week